Why MOTS-C continues gaining visibility across peptide listings?

  Visibility within peptide supply listings reflects more than catalogue additions. A compound gains sustained listing presence when institutional demand deepens across multiple procurement cycles, distribution partners invest in fulfilment infrastructure around it, and procurement coordinators begin treating it as a recurring sourcing category rather than a one-time specialty acquisition. Supply chain specialists and research […]